Posts for Ticker ‘ZMH’

Top Analyst Upgrades & Downgrades (APA, JPM, JCOM, FCX, PLD, RTP, SLB, SCR, SLM, TXN, UNH, X, ZMH)

These are this morning’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls:

Apache Corp. (NYSE: APA) Started as Sector Underperform at Scotia.
JPMorgan Chase & Co. (NYSE: JPM) Raised to Buy at Citigroup.
j2 Global Communications (NASDAQ: JCOM) Raised to Outperform at Morgan Keegan.
Freeport McMoRan (NYSE: FCX) Cut to Neutral from buy at Goldman Sachs.
ProLogis (NYSE: PLD) Cut to Underperform at Wells Fargo.
Rio Tinto (NYSE: RTP) Raised to Overweight from Neutral at HSBC.
Schlumberger Ltd. (NYSE: SLB) Raised to Buy at Calyon.
Simcere Pharmaceutical Group (NYSE: SCR) Cut to Perform at Oppenheimer.
SLM Corp. (NYSE: SLM) Cut to Neutral at Ladenberg Thalmann.
Texas Instruments (NYSE: TXN) Raised estimates but Maintained Sell at Auriga.
UnitedHealth Group (NYSE: UNH) Raised to Conviction Buy List at Goldman Sachs.
United States Steel (NYSE: X) Cut to Buy from Conviction Buy at Goldman Sachs.
Zimmer Holdings (NYSE: ZMH) Started as Buy at Jefferies.

You are invited to join our free daily email distribution list to hear about top analyst upgrades and downgrades, IPOs and secondary offerings, ongoing day trader and options trader alerts, stock and market rumors, Buffett and guru investor news, M&A and more.

JON C. OGG

Posted on: January 22, 2010 – 8:30 am in Analyst Calls, , , , , , , , , , , , ,

Top Analyst Upgrades (AMD, AXP, ACI, ASH, STD, BRCD, COF, DFS, HIBB, MSCC, RCL, ZMH)

There were quite a few analyst upgrades and positive research calls this Monday morning.  These are the calls we have seen from Wall Street firms early this morning with about two hours until the market opens:

Advanced Micro Devices (AMD) Raised to Buy at Citigroup.
American Express (AXP) Raised to Overweight at Barclays.
Arch Coal (ACI) Raised to Overweight at JPMorgan.
Ashland (ASH) Raised to Buy at KeyBanc.
Banco Santander (STD) Raised to Overweight at JPMorgan.
Brocade (BRCD) Raised to Buy at Argus.
Capital One (COF) Raised to Overweight at Barclays.
Discover Financial (DFS) Raised to Overweight at Barclays.
Hibbett Sports (HIBB) Raised to Overweight at JPMorgan.
Microsemi (MSCC) Raised to Overweight at Thomas Weisel.
Royal Caribbean (RCL) Raised to Buy at Argus.
Zimmer Holdings (ZMH) Raised to Overweight at Thomas Weisel.

If you wish to be reminded of daily upgrades and downgrades as well as other key market issues like mergers and top stories, you can join our open email distribution list to receive updates several times per week.

JON C. OGG

Posted on: August 24, 2009 – 7:58 am in Analyst Calls, , , , , , , , , , , ,

Top Pre-Market Analyst Downgrades (ADCT, ALV, CAT, FORM, GMR, GIII, MIR, SNIC, TGT, TOPS, WM, ZMH)

These are some of the top downgrades or negative analyst calls we are seeing this Wednesday morning in early pre-market hours:

  • ADC Telecom (ADCT) Cut to Neutral at Baird; Cut to Market Perform at FBR.
  • Autoliv (ALV) Cut to Hold at Deutsche Bank.
  • Caterpillar (CAT) Cut to Neutral at JPMorgan.
  • FormFactor (FORM) Cut to Perform  at Oppenheimer.
  • General Maritime (GMR) Cut to Neutral at JPMorgan.
  • G-III Apparel Group (GIII) Cut to Market Weight at Thomas Weisel.
  • Mirant (MIR) Cut to Equal Weight at Lehman.
  • Sonic Solutions (SNIC) Cut to Neutral at JPMorgan.
  • Target Corp. (TGT) Cut to Neutral at Credit Suisse.
  • Top Ships (TOPS) Cut to Underweight at JPMorgan.
  • Washington Mutual (WM) Cut to Sell at Piper Jaffray.
  • Zimmer Holdings (ZMH) Cut to Neutral at Piper Jaffray.

Jon C. Ogg
July 23, 2008

Posted on: July 23, 2008 – 6:29 am in Analyst Calls, , , , , , , , , , , ,

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading:

  • Abbott Laboratories (NYSE: ABT) Raised To Outperform at Wachovia.
  • Altria (NYSE: MO) started as Buy at UBS.
  • Amgen (NASDAQ: AMGN) downgraded to Market Perform at Wachovia.
  • Cardiome Pharma (NASDAQ: CRME) started At Outperform at Wachovia.
  • Fannie Mae (NYSE: FNM) raised to Outperform at KBW.
  • Freddie Mac (NYSE: FRE) raised to Outperform at KBW.
  • ICICI Bank (NYSE: IBN) downgraded to Underperform at Jefferies.
  • Panera Bread (NASDAQ: PNRA)  downgraded to Neutral at JP Morgan.
  • SanDisk NASDAQ: SNDK) downgraded to Neutral at JP Morgan.
  • Zimmer Holdings (NYSE: ZMH) raised to Overweight at Lehman Brothers.

Jon C. Ogg
March 20, 2008

Posted on: March 20, 2008 – 6:28 am in Analyst Calls, , , , , , , , , ,

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag.  GlaxoSmithkline (GSK) saw the lagest increase, but its short interest is not representative of its real size or activity because it is an ADR and less active here compared to U.K. trade volume.  We ranked hese in terms of percentages with the largest increase in short interest first.

STOCK (Ticker)                JUNE07      MAY07     Change
GlaxoSmithkline (GSK)     7.74M         4.15M       +86%
Boston Scientific (BSX)   32.07M       24.06M       +33.3%
Wyeth (WYE)                          3.3M       10.37M       +28.3%
Labcorp (LH)                       4.11M         3.21M       +28%
Bristol-Myers (BMY)          26.95M       23.85M      +13%
Schering-Plough (SGP)   16.79M      15.27M       +9.9%
Medtronic (MDT)                16.11M      15.19M        +6%
Pfizer (PFE)                        54.48M       52.12M       +4.5%
Quest Diagnost. (DGX)    18.00M       17.54M       +2.6%
Merck (MRK)                       22.82M       22.55M       +1.2%
Eli Lilly (LLY)                       13.77M       14.07M        -2.1%
J&J (JNJ)                             15.37M      16.16M        -4.9%
Zimmer Holdings (ZMH)     3.89M         4.13M        -5.8%
St. Jude MEdical (STJ)        6.53M         7.13M         -8.4%
Genentech (DNA)                 6.87M         8.16M        -15.9%
Abbott Labs (ABT)              11.74M       16.39M        -28.3%

Jon C. Ogg
June 24, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 24, 2007 – 12:16 pm in Biotech, Drug companies, Medical, Short Interest, , , , , , , , , , , , , , , ,

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is the actual posting from April to May:

STOCK (Ticker)                        MAY07    APR07    Change
Pfizer (PFE)                               52.12M    50.28M    3.6%
Merck (MRK)                             22.55M    18.68M    20.6%
Johnson & Johnson (JNJ)    16.16M    14.47M    11.7%
Abbott Labs (ABT)                   16.39M    14.90M    10%
Wyeth (WYE)                            10.37M    9.61M       7.9%
Eli Lilly (LLY)                            14.07M    10.95M    28.5%
Bristol-Myers (BMY)                23.85M    18.75M    27.2%
Schering-Plough (SGP)        15.27M    14.09M      8.3%
Medtronic (MDT)                      15.19M    13.81M     9.9%
Boston Scientific (BSX)          24.06M    21.65M     11.1%
St. Jude MEdical (STJ)             7.13M    5.85M        21.8%
Quest Diagnost. (DGX)          17.54M    16.57M     11.1%

lower short interest…..

GlaxoSmithkline (GSK)            5.15M    4.66M    -11%
Genentech (DNA)                      8.16M    8.76M    -6.8%
Zimmer Holdings (ZMH)          4.13M    5.00M    -17%
Labcorp (LH)                              3.21M    3.34M    -3.9%

Jon C. Ogg
May 22, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: May 22, 2007 – 4:36 pm in Drug companies, Medical, Pharmaceuticals, Short Interest, , , , , , , , , , , , , , , ,